Two significant programs that invested in research on diabetes, dementia, obesity and kidney disease have ended since the ...

For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people ...

Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...

Diabetes and high blood pressure are the two main culprits of chronic kidney disease (CKD), a long-term condition in which ...

Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor ...

Chronic Kidney Disease (CKD) affects approximately 15% of U.S. adults and as many as 9 in 10 with CKD are unaware they have ...

Chicago: For a disease afflicting 35.5 million people in the US, chronic kidney disease flies under the radar. Only half the people who have it are formally diagnosed. The consequences of advanced ...

In March 2025, Shandong Suncadia Medicine Co., Ltd. conducted a phase II Clinical Study of Efficacy and Safety of HRS-1780 ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...